A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus.

MLA

Hobson-Peters, Jody, et al. “A Recombinant Platform for Flavivirus Vaccines and Diagnostics Using Chimeras of a New Insect-Specific Virus.” Science Translational Medicine, vol. 11, no. 522, Dec. 2019. EBSCOhost, https://doi.org/10.1126/scitranslmed.aax7888.

APA

Hobson-Peters, J., Harrison, J. J., Watterson, D., Hazlewood, J. E., Vet, L. J., Newton, N. D., Warrilow, D., Colmant, A. M. G., Taylor, C., Huang, B., Piyasena, T. B. H., Chow, W. K., Setoh, Y. X., Tang, B., Nakayama, E., Yan, K., Amarilla, A. A., Wheatley, S., Moore, P. R., … Hall, R. A. (2019). A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virus. Science Translational Medicine, 11(522). https://doi.org/10.1126/scitranslmed.aax7888

Chicago

Hobson-Peters, Jody, Jessica J Harrison, Daniel Watterson, Jessamine E Hazlewood, Laura J Vet, Natalee D Newton, David Warrilow, et al. 2019. “A Recombinant Platform for Flavivirus Vaccines and Diagnostics Using Chimeras of a New Insect-Specific Virus.” Science Translational Medicine 11 (522). doi:10.1126/scitranslmed.aax7888.